跳至主要内容
临床试验/NCT02045641
NCT02045641已完成不适用

The Clinical Impact of an Aggressive Approach Towards Pleural and Pericardial Effusions Following Open Heart Surgery: a Step Towards Standard Guidelines

Aarhus University Hospital Skejby2 个研究点 分布在 1 个国家目标入组 76 人开始时间: 2013年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
76
试验地点
2
主要终点
change in walking distance before and after intervention

研究概览

简要总结

One of the most common postoperative complications after open cardiac surgery is fluid accumulation between the pleural membranes or in the pericardial sac. This study investigates the consequence of such fluid accumulations on physical performance, recovery-time, cardiac and respiratory complications, and quality of life. Half of the participants will be followed closely and offered fluid drainage at a low threshold, and half of the participants will follow the current postoperative regimen.

详细描述

Introduction:

Knowledge concerning the impact of pleural and pericardial effusions on physical performance, recovery-time, cardiac and respiratory complications, and quality of life after open cardiac surgery is scarce. A more aggressive approach towards effusions has been suggested, but further studies are needed.

Objectives:

  1. to determine the size of pleural and pericardial effusion that results in at least 30% reduction of physical performance in the 6-minute walk test.
  2. to compare the improvement in physical performance between the intervention group and the control group, measured from baseline to day 30 after surgery.

Materials and methods:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >18 years.
  • Admitted for elective aortic valve surgery, coronary artery bypass graft surgery or combinations.
  • Be able to understand the written and oral patient information and to give informed consent.

排除标准

  • Surgical combinations involving the mitral valve since they are already examined with full echocardiography prior to discharge, which may influence protocol driven decisions.
  • Simultaneous participation in any other clinical intervention trial

结局指标

主要结局

change in walking distance before and after intervention

时间窗: day 4, day 15, day 30

The primary outcome measure is the change in walking distance before and after pleuracentesis, subsequently the size of pleural effusion (both cm measured on ultrasound and drained volume) that results in a reduction of distance in the 6 minute walk test of at least 30%.

次要结局

  • change in walking distance from baseline to day 30 after surgery(day 0 and day 30)

研究者

发起方
Aarhus University Hospital Skejby
申办方类型
Other
责任方
Principal Investigator
主要研究者

Laura Sommer Hansen

MD PHD fellow

Aarhus University Hospital Skejby

研究点 (2)

Loading locations...

相似试验